Related Experiment Video
Updated: Mar 3, 2026
Microfluidics in Assessing Platelet Function
Published on: November 8, 2024
Correlation of platelet count and acute ST-elevation in myocardial infarction
Insights
Higher platelet counts in ST-elevation myocardial infarction (STEMI) patients correlate with poorer outcomes. This finding suggests platelet count can aid in risk stratification and treatment decisions for acute myocardial infarction (AMI).
Area of Science:
- Cardiology
- Hematology
Background:
- Platelets play a key role in ST-elevation myocardial infarction (STEMI) pathogenesis.
- Antiplatelet therapy has demonstrated significant clinical benefits in STEMI patients.
Purpose of the Study:
- To investigate the association between initial platelet counts and clinical outcomes in STEMI patients.
- To evaluate the utility of platelet count for risk stratification in Acute Myocardial Infarction (AMI).
Main Methods:
- Analysis of initial platelet counts in patients presenting with STEMI.
- Comparison of outcomes based on varying platelet count levels.
Main Results:
- Higher platelet counts in STEMI patients are linked to poorer in-hospital outcomes.
- Elevated platelet counts correlate with increased rates of heart failure, arrhythmia, re-infarction, and death.
- Platelet count may predict response to fibrinolytic agents in AMI.
Conclusions:
- Initial platelet count is a valuable predictor of adverse clinical outcomes in STEMI.
- Categorizing STEMI patients by platelet count can assist in risk stratification and management strategies.
Abstract:
The role of platelets in the pathogenesis of ST-elevation myocardial infarction (STEMI) has been substantiated by studies that demonstrated significant clinical benefits associated with antiplatelet therapy. Initial platelet counts in Acute Myocardial Infarction (AMI) may be a useful adjunct for identifying those patients who may or may not respond to fibrinolytic agents. Patient with acute STEMI has variable level of platelet count and with higher platelet count have poor in hospital outcome. There are many predictors of poor outcome in Acute Myocardial Infarction (AMI) like cardiac biomarkers (Troponin I, Troponin T and CK-MB), C-Reactive Protien (CRP) and WBC (White Blood Cell) counts. Platelet count on presentation of STEMI is one of them. Higher platelet count is associated with higher rate of adverse clinical outcome in ST-Elevation Myocardial Infarction (STEMI), like heart failure, arrhythmia, re-infarction & death. So, categorization of patient with STEMI on the basis of platelet counts may be helpful for risk stratification and management of these patients.
More Related Videos
04:41Digital PCR for Quantifying Circulating MicroRNAs in Acute Myocardial Infarction and Cardiovascular Disease
Published on: July 3, 2018
18:11A Research Method For Detecting Transient Myocardial Ischemia In Patients With Suspected Acute Coronary Syndrome Using Continuous ST-segment Analysis
Published on: December 28, 2012
Related Concept Videos
01:28Acute Coronary Syndrome IV: Interprofessional Care
01:30Acute Coronary Syndrome III: Diagnostic Studies
01:19Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations
01:30Acute Coronary Syndrome I: Introduction
01:22Formation of the Platelet Plug
As the injured blood vessel contracts, endothelial cells undergo contraction, revealing collagen fibers in the basement membrane and underlying connective tissue. Furthermore, the plasma membrane of endothelial cells becomes adhesive, preparing the site for platelet adhesion. Platelets...
01:20Blood Studies for Cardiovascular System I: Cardiac Biomarkers
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...